通化东宝：产品门冬胰岛素注射液取得注册证

Group 1 - Tonghua Dongbao Pharmaceutical Co., Ltd. has recently received the drug registration certificate for insulin aspart injection from the Indonesian Food and Drug Authority [1] - The Chinese innovative drug sector has sold overseas authorizations worth $80 billion this year [1] - The secondary market for biopharmaceuticals is currently thriving, while the primary market is experiencing a cooling in fundraising [1]